← Leaderboards
Mukesh Kumar Jain
Brown University
$33,515,305
Attributed
$35,260,163
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–23$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$35,260,163 · 18
By mechanism
R01$23,423,961 · 12
R35$6,663,000 · 1
T32$3,705,554 · 2
P01$1,097,547 · 1
K08$369,360 · 1
T35$741 · 1
Top collaborators
- Keith R. Mccrae4 shared
- Aaron Proweller4 shared
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularTranscription FactorIn VivoFoundationsInsightBaseMediatingGene ExpressionInflammatoryBlood VesselsPathway InteractionsInflammationFamilyOverexpressionZinc FingersStimulusCellsPhenotypeAtherosclerosisPathologicCytokineResponseIn VitroCellular Biology
Grant awards (89)
KLF control of aging and age-associated cardiovascular disease$957,000
R35 · FY2023 · HL · contact PI
KLF control of aging and age-associated cardiovascular disease$951,000
R35 · FY2022 · HL · contact PI
KLF control of aging and age-associated cardiovascular disease$951,000
R35 · FY2021 · HL · contact PI
CWRU- Cardiovascular Research Training Program$286,648
T32 · FY2021 · HL
KLF control of aging and age-associated cardiovascular disease$951,000
R35 · FY2020 · HL · contact PI
CWRU- Cardiovascular Research Training Program$490,194
T32 · FY2020 · HL
KLF15 in skeletal muscle lipid metabolism$336,089
R01 · FY2020 · DK · contact PI
KLF control of aging and age-associated cardiovascular disease$951,000
R35 · FY2019 · HL · contact PI
CWRU- Cardiovascular Research Training Program$472,032
T32 · FY2019 · HL
KLF15 in skeletal muscle lipid metabolism$336,089
R01 · FY2019 · DK · contact PI
KLF control of aging and age-associated cardiovascular disease$951,000
R35 · FY2018 · HL · contact PI
CWRU- Cardiovascular Research Training Program$451,772
T32 · FY2018 · HL
KLF15 in skeletal muscle lipid metabolism$336,392
R01 · FY2018 · DK · contact PI
KLF control of aging and age-associated cardiovascular disease$951,000
R35 · FY2017 · HL · contact PI
Transcriptional control of endothelium in APS by Kruppel Like factors$448,951
R01 · FY2017 · HL
KLF15 in skeletal muscle lipid metabolism$350,412
R01 · FY2017 · DK · contact PI
CWRU- Cardiovascular Research Training Program$223,992
T32 · FY2017 · HL · contact PI
KLF15 in Cardiac Metabolism$55,613
R01 · FY2017 · HL · contact PI
Transcriptional control of endothelium in APS by Kruppel Like factors$448,951
R01 · FY2016 · HL
KLF2, monocyte activation and vascular inflammation$408,131
R01 · FY2016 · HL · contact PI
KLF15 in Cardiac Metabolism$396,250
R01 · FY2016 · HL · contact PI
KLF15 in vascular disease$490,620
R01 · FY2015 · HL · contact PI
Transcriptional control of endothelium in APS by Kruppel Like factors$442,217
R01 · FY2015 · HL
KLF2, monocyte activation and vascular inflammation$402,008
R01 · FY2015 · HL · contact PI
KLF15 in Cardiac Metabolism$390,306
R01 · FY2015 · HL · contact PI
KLF15 in vascular disease$488,129
R01 · FY2014 · HL · contact PI
Transcriptional control of endothelium in APS by Kruppel Like factors$448,951
R01 · FY2014 · HL
KLF2, monocyte activation and vascular inflammation$399,968
R01 · FY2014 · HL · contact PI
KLF15 in Cardiac Metabolism$396,250
R01 · FY2014 · HL · contact PI
KLF4 and Myeloid Cell Biology$384,650
R01 · FY2014 · HL · contact PI
Cardiovascular Research Training Program (CRTP)$250,832
T32 · FY2014 · HL · contact PI
KLF15 in vascular disease$474,183
R01 · FY2013 · HL · contact PI
Cardiovascular Research Training Program (CRTP)$444,517
T32 · FY2013 · HL · contact PI
KLF2, monocyte activation and vascular inflammation$406,522
R01 · FY2013 · HL · contact PI
KLF4 and Myeloid Cell Biology$373,660
R01 · FY2013 · HL · contact PI
KLF4 , the endothelium, and vascular inflammation$369,923
R01 · FY2013 · HL · contact PI
KLF15 in vascular disease$494,948
R01 · FY2012 · HL · contact PI
Cardiovascular Research Training Program (CRTP)$444,517
T32 · FY2012 · HL · contact PI
KLF4 and Myeloid Cell Biology$392,500
R01 · FY2012 · HL · contact PI
KLF2 as a regulator of endothelial cell biology$388,575
R01 · FY2012 · HL · contact PI
KLF4 , the endothelium, and vascular inflammation$388,575
R01 · FY2012 · HL · contact PI
KLF4 , the endothelium, and vascular inflammation$392,500
R01 · FY2011 · HL · contact PI
KLF4 and Myeloid Cell Biology$392,500
R01 · FY2011 · HL · contact PI
KLF2 as a regulator of endothelial cell biology$392,500
R01 · FY2011 · HL · contact PI
KLF2 monocyte activation and vascular inflammation$386,250
R01 · FY2011 · HL · contact PI
Cardiovascular Research Training Program (CRTP)$325,994
T32 · FY2011 · HL · contact PI
KLF4, Monocyte Biology and Vasculary Injury$490,627
R01 · FY2010 · HL · contact PI
KLF4 , the endothelium, and vascular inflammation$392,500
R01 · FY2010 · HL · contact PI
KLF2 as a regulator of endothelial cell biology$392,500
R01 · FY2010 · HL · contact PI
KLF15 as novel regulator of cardiomyocyte biology$386,250
R01 · FY2010 · HL · contact PI
KLF2 monocyte activation and vascular inflammation$386,250
R01 · FY2010 · HL · contact PI
Cardiovascular Research Training Program (CRTP)$315,056
T32 · FY2010 · HL · contact PI
KLF4, Monocyte Biology and Vasculary Injury$490,627
R01 · FY2009 · HL · contact PI
KLF2 as a regulator of endothelial cell biology$392,500
R01 · FY2009 · HL · contact PI
KLF15 as novel regulator of cardiomyocyte biology$386,250
R01 · FY2009 · HL · contact PI
KLF2 monocyte activation and vascular inflammation$386,250
R01 · FY2009 · HL · contact PI
KLF2, Diabetes and Gene Regulation in Endothelial Cells$374,455
P01 · FY2009 · HL · contact PI
NHLBI Research Opportunities for Minority Students$741
T35 · FY2009 · HL · contact PI
KLF2 monocyte activation and vascular inflammation$386,250
R01 · FY2008 · HL · contact PI
KLF15 as novel regulator of cardiomyocyte biology$386,250
R01 · FY2008 · HL · contact PI
KLF2 as a regulator of endothelial cell biology$377,173
R01 · FY2008 · HL · contact PI
KLF2, Diabetes and Gene Regulation in Endothelial Cells$363,348
P01 · FY2008 · HL · contact PI
KLF15 as novel regulator of cardiomyocyte biology$386,250
R01 · FY2007 · HL · contact PI
KLF2 monocyte activation and vascular inflammation$386,250
R01 · FY2007 · HL · contact PI
KLF4 monocyte biology and vascular injury$366,235
R01 · FY2007 · HL · contact PI
KLF2, Diabetes and Gene Regulation in Endothelial Cells$359,740
P01 · FY2007 · HL · contact PI
KLF15, TGFb1 and smooth muscle cell biology$344,309
R01 · FY2007 · HL · contact PI
KLF2 as a regulator of endothelial cell biology$377,173
R01 · FY2006 · HL · contact PI
KLF4 monocyte biology and vascular injury$342,271
R01 · FY2006 · HL · contact PI
KLF15, TGFb1 and smooth muscle cell biology$214,256
R01 · FY2006 · HL · contact PI
KLF15, TGFb1 and smooth muscle cell biology$177,835
R01 · FY2006 · HL · contact PI
KLF4 monocyte biology and vascular injury$72,937
R01 · FY2006 · HL · contact PI
KLF2, Diabetes and Gene Regulation in Endothelial Cells$2
P01 · FY2006 · HL · contact PI
KLF2 as a regulator of endothelial cell biology$425,200
R01 · FY2005 · HL
KLF4 monocyte biology and vascular injury$425,200
R01 · FY2005 · HL
KLF15, TGFb1 and smooth muscle cell biology$401,527
R01 · FY2005 · HL
KLF2 as a regulator of endothelial cell biology$52,450
R01 · FY2005 · HL
KLF2, Diabetes and Gene Regulation in Endothelial Cells$2
P01 · FY2005 · HL
KLF2 as a regulator of endothelial cell biology$425,200
R01 · FY2004 · HL
KLF4 monocyte biology and vascular injury$425,200
R01 · FY2004 · HL
KLF15, TGFb1 and smooth muscle cell biology$396,052
R01 · FY2004 · HL
Smad3 as an inhibitor of atherogenesis$373,920
R01 · FY2004 · HL
Smad3 as an inhibitor of atherogenesis$400,446
R01 · FY2003 · HL
Smad3 as an inhibitor of atherogenesis$33,851
R01 · FY2003 · HL
Smad3 as an inhibitor of atherogenesis$373,580
R01 · FY2002 · HL
SMLIM, A VASCULAR SMOOTH MUSCLE LIM PROTEIN$123,120
K08 · FY2002 · HL
Smad3 as an inhibitor of atherogenesis$357,779
R01 · FY2001 · HL
SMLIM, A VASCULAR SMOOTH MUSCLE LIM PROTEIN$123,120
K08 · FY2001 · HL
SMLIM, A VASCULAR SMOOTH MUSCLE LIM PROTEIN$123,120
K08 · FY2000 · HL